{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:54:14Z","timestamp":1770742454666,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Histiocytic sarcoma (HS) is defined as neoplasm resembling morphological and immunophenotypic characteristics of mature histiocytes. It is a rare form of lymphoid neoplasms. Despite advances in treatment and diagnosis of histiocytic sarcoma, majority of cases had poor prognosis due to progressive nature of the disease. In the following article, all reported cases of histiocytic sarcoma in renal transplant patients are reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In our literature review, all relevant reports were collected electronically by entering the necessary keywords. A Boolean approach using Medical Subject Heading (MeSH) keywords was implemented. After establishing the inclusion\/exclusion criteria, article titles and abstracts were evaluated by Systematic Reviews and Meta-Analyses (PRISMA) standards for 2020. All cases of histiocytic sarcoma in renal transplant patients were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Based on our inclusion and exclusion criteria 4 case reports were yielded in this review. Two were males and 2 were females with the mean age of 42.25\u00a0years. Fever was the most common symptom. Although tumor originated from the native kidney on one patient, the site of the primary tumor was thorax, oropharynx, and transplanted kidney in the rest. Metastasis was detected in all cases. Prednisone was used for all cases. EBV was positive in 2 cases and negative in one of them. Histology was diagnostic and similar in all cases. Immunohistochemistry was done for 3 cases. Although chemotherapy was done for 3 patients, all 4 cases ended in mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite the fact that neoplasms are post renal transplant complications, histiocytic sarcoma is a scarce and fatal entity in such patients. Histological and immunohistochemistry tests are the corner stone in diagnosis of histiocytic sarcoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04140-4","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:01:57Z","timestamp":1696291317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Histiocytic sarcoma in renal transplant patients: a literature review"],"prefix":"10.1186","volume":"17","author":[{"given":"Mahsa","family":"Salehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafi","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miraa","family":"Qutab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruba","family":"Altheeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"1","key":"4140_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013;53(1):1\u20138.","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"4140_CR2","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83\u20137.","journal-title":"Pathologica"},{"issue":"9","key":"4140_CR3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","volume":"28","author":"JL Hornick","year":"2004","unstructured":"Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28(9):1133\u201344.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4140_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2350\/09-03-0622-OA.1","volume":"13","author":"EC Castro","year":"2010","unstructured":"Castro EC, Blazquez C, Boyd J, Correa H, de Chadarevian JP, Felgar RE, et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010;13(3):225\u201337.","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"4140_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2169\/internalmedicine.47.0386","volume":"47","author":"C Yoshida","year":"2008","unstructured":"Yoshida C, Takeuchi M. Histiocytic sarcoma: identification of its histiocytic origin using immunohistochemistry. Intern Med. 2008;47(3):165\u20139.","journal-title":"Intern Med"},{"key":"4140_CR6","first-page":"3591050","volume":"2016","author":"M Pollen","year":"2016","unstructured":"Pollen M, El Jamal S, Lewin J, Manucha V. Histiocytic sarcoma in a kidney transplant patient: a case report and review of the literature. Case Rep Pathol. 2016;2016:3591050.","journal-title":"Case Rep Pathol"},{"issue":"3","key":"4140_CR7","first-page":"97","volume":"4","author":"P Ventura Aguiar","year":"2015","unstructured":"Ventura Aguiar P, Dias C, Azevedo P, Silva HN, Almeida M, Pedroso S, et al. Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient. J Nephropathol. 2015;4(3):97\u2013100.","journal-title":"J Nephropathol"},{"key":"4140_CR8","volume":"2015","author":"J Tomlin","year":"2015","unstructured":"Tomlin J, Orosco RK, Boles S, Tipps A, Wang HY, Husseman J, et al. Successful treatment of multifocal histiocytic sarcoma occurring after renal transplantation with cladribine, high-dose cytarabine, G-CSF, and mitoxantrone (CLAG-M) followed by allogeneic hematopoietic stem cell transplantation. Case Rep Hematol. 2015;2015: 728260.","journal-title":"Case Rep Hematol"},{"issue":"3","key":"4140_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1097-0142(19850201)55:3<503::AID-CNCR2820550305>3.0.CO;2-2","volume":"55","author":"P Kramer","year":"1985","unstructured":"Kramer P, Prins ME, Kapsenberg JG, Bornkamm GW, Bijnen AB, Rohol PJ, et al. Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer. 1985;55(3):503\u20139.","journal-title":"Cancer"},{"issue":"1","key":"4140_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.","journal-title":"Syst Rev"},{"issue":"3","key":"4140_CR11","first-page":"136","volume":"10","author":"S Boubenider","year":"1997","unstructured":"Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B. Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol. 1997;10(3):136\u201345.","journal-title":"J Nephrol"},{"issue":"1","key":"4140_CR12","first-page":"1121","volume":"9","author":"I Penn","year":"1977","unstructured":"Penn I. Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977;9(1):1121\u20137.","journal-title":"Transplant Proc"},{"issue":"7","key":"4140_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJM197908163010716","volume":"301","author":"I Penn","year":"1979","unstructured":"Penn I. Tumors in allograft recipients. N Engl J Med. 1979;301(7):385.","journal-title":"N Engl J Med"},{"issue":"1 Pt 2","key":"4140_CR14","first-page":"736","volume":"13","author":"I Penn","year":"1981","unstructured":"Penn I. Malignant lymphomas in organ transplant recipients. Transplant Proc. 1981;13(1 Pt 2):736\u20138.","journal-title":"Transplant Proc"},{"key":"4140_CR15","doi-asserted-by":"crossref","unstructured":"Tumour viruses. Lancet. 1982;1(8267):317\u20138.","DOI":"10.1016\/S0140-6736(82)91573-2"},{"issue":"8273","key":"4140_CR16","first-page":"684","volume":"1","author":"DT Purtilo","year":"1982","unstructured":"Purtilo DT. Viruses, tumours, and immune deficiency. Lancet. 1982;1(8273):684.","journal-title":"Lancet"},{"issue":"1","key":"4140_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","volume":"41","author":"SA Pileri","year":"2002","unstructured":"Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41(1):1\u201329.","journal-title":"Histopathology"},{"issue":"1","key":"4140_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1600-6135.2003.00274.x","volume":"4","author":"RT Bustami","year":"2004","unstructured":"Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant. 2004;4(1):87\u201393.","journal-title":"Am J Transplant"},{"issue":"2","key":"4140_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4(2):222\u201330.","journal-title":"Am J Transplant"},{"issue":"5","key":"4140_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1309\/QHD6YFN81KQXUUH6","volume":"122","author":"SK Lau","year":"2004","unstructured":"Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004;122(5):794\u2013801.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"4140_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3109\/10428191003699845","volume":"51","author":"E Wang","year":"2010","unstructured":"Wang E, Hutchinson CB, Huang Q, Sebastian S, Rehder C, Kanaly A, et al. Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular\/genetic evidence suggestive of a \u2018transdifferentiation\u2019 during the clonal evolution. Leuk Lymphoma. 2010;51(5):802\u201312.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"4140_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1440-1827.2011.02671.x","volume":"61","author":"J Akiba","year":"2011","unstructured":"Akiba J, Harada H, Kawahara A, Arakawa F, Mihashi H, Mihashi R, et al. Histiocytic sarcoma of the parotid gland region. Pathol Int. 2011;61(6):373\u20136.","journal-title":"Pathol Int"},{"issue":"4","key":"4140_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3415\/VCOT-07-05-0054","volume":"21","author":"GL Harasen","year":"2008","unstructured":"Harasen GL, Simko E. Histiocytic sarcoma of the stifle in a dog with cranial cruciate ligament failure and TPLO treatment. Vet Comp Orthop Traumatol. 2008;21(4):375\u20137.","journal-title":"Vet Comp Orthop Traumatol"},{"issue":"12","key":"4140_CR24","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","volume":"111","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, et al. Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111(12):5433\u20139.","journal-title":"Blood"},{"issue":"1","key":"4140_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/TP.0b013e3182782f59","volume":"95","author":"AD Hibberd","year":"2013","unstructured":"Hibberd AD, Trevillian PR, Wlodarczyk JH, Kemp DG, Stein AM, Gillies AH, et al. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study. Transplantation. 2013;95(1):122\u20137.","journal-title":"Transplantation"},{"issue":"2","key":"4140_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2021.01.015","volume":"78","author":"B Sprangers","year":"2021","unstructured":"Sprangers B, Riella LV, Dierickx D. Posttransplant lymphoproliferative disorder following kidney transplantation: a review. Am J Kidney Dis. 2021;78(2):272\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"8886\u20138887","key":"4140_CR27","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","volume":"342","author":"G Opelz","year":"1993","unstructured":"Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342(8886\u20138887):1514\u20136.","journal-title":"Lancet"},{"issue":"3","key":"4140_CR28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood-2009-02-202507","volume":"114","author":"MT van Leeuwen","year":"2009","unstructured":"van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, et al. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood. 2009;114(3):630\u20137.","journal-title":"Blood"},{"issue":"8","key":"4140_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/00007890-199910270-00024","volume":"68","author":"JD Pirsch","year":"1999","unstructured":"Pirsch JD. Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. Transplantation. 1999;68(8):1203\u20135.","journal-title":"Transplantation"},{"issue":"9","key":"4140_CR30","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1016\/j.transproceed.2008.09.025","volume":"40","author":"MD Navarro","year":"2008","unstructured":"Navarro MD, Lopez-Andreu M, Rodriguez-Benot A, Aguera ML, Del Castillo D, Aljama P. Cancer incidence and survival in kidney transplant patients. Transplant Proc. 2008;40(9):2936\u201340.","journal-title":"Transplant Proc"},{"issue":"2","key":"4140_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/ajt.13558","volume":"16","author":"JF Ferreiro","year":"2016","unstructured":"Ferreiro JF, Morscio J, Dierickx D, Vandenberghe P, Gheysens O, Verhoef G, et al. EBV-positive and EBV-negative posttransplant diffuse large B cell lymphomas have distinct genomic and transcriptomic features. Am J Transplant. 2016;16(2):414\u201325.","journal-title":"Am J Transplant"},{"issue":"10","key":"4140_CR32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/modpathol.2016.130","volume":"29","author":"EL Courville","year":"2016","unstructured":"Courville EL, Yohe S, Chou D, Nardi V, Lazaryan A, Thakral B, et al. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations. Mod Pathol. 2016;29(10):1200\u201311.","journal-title":"Mod Pathol"},{"issue":"1","key":"4140_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12307-018-00219-5","volume":"12","author":"L Marcelis","year":"2019","unstructured":"Marcelis L, Tousseyn T. The tumor microenvironment in post-transplant lymphoproliferative disorders. Cancer Microenviron. 2019;12(1):3\u201316.","journal-title":"Cancer Microenviron"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04140-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:17:29Z","timestamp":1700457449000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04140-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4140"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04140-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}